Longeveron LLC

Company Profile

Longeveron LLC had its IPO on 2021-02-12 under the ticker symbol LGVN.

The company operates in the Healthcare sector and Biotechnology industry. Longeveron LLC has a staff strength of 19 employees.

Stock update

Shares of Longeveron LLC opened at $2.37 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $2.37 - $2.68, and closed at $2.43.

This is a 0% increase from the previous day's closing price.

A total volume of 138,699 shares were traded at the close of the day’s session.

In the last one week, shares of Longeveron LLC have slipped by -7.95%.

Longeveron LLC's Key Ratios

Longeveron LLC has a market cap of $55.88 million, indicating a price to book ratio of 2.8691 and a price to sales ratio of 51.5031.

In the last 12-months Longeveron LLC’s revenue was $882000 with a gross profit of $497000 and an EBITDA of $-19596000. The EBITDA ratio measures Longeveron LLC's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Longeveron LLC’s operating margin was -2329.93% while its return on assets stood at -49.01% with a return of equity of -98.32%.

In Q2, Longeveron LLC’s quarterly earnings growth was a positive 0% while revenue growth was a negative 53.4%.

Longeveron LLC’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.97 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Longeveron LLC’s profitability.

Longeveron LLC stock is trading at a EV to sales ratio of 38.9678 and a EV to EBITDA ratio of -2.9077. Its price to sales ratio in the trailing 12-months stood at 51.5031.

Longeveron LLC stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$17.09 million

Total Liabilities

$4.08 million

Operating Cash Flow

$2.45 million

Capital Expenditure

$205000

Dividend Payout Ratio

0%

Longeveron LLC ended 2024 with $17.09 million in total assets and $0 in total liabilities. Its intangible assets were valued at $17.09 million while shareholder equity stood at $11.26 million.

Longeveron LLC ended 2024 with $0 in deferred long-term liabilities, $4.08 million in other current liabilities, 21000.00 in common stock, $-73052000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $2.75 million and cash and short-term investments were $8.66 million. The company’s total short-term debt was $578,000 while long-term debt stood at $0.

Longeveron LLC’s total current assets stands at $10.29 million while long-term investments were $0 and short-term investments were $5.91 million. Its net receivables were $96000.00 compared to accounts payable of $1.70 million and inventory worth $0.

In 2024, Longeveron LLC's operating cash flow was $2.45 million while its capital expenditure stood at $205000.

Comparatively, Longeveron LLC paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$2.43

52-Week High

$4.935

52-Week Low

$2.23

Analyst Target Price

$13.6

Longeveron LLC stock is currently trading at $2.43 per share. It touched a 52-week high of $4.935 and a 52-week low of $4.935. Analysts tracking the stock have a 12-month average target price of $13.6.

Its 50-day moving average was $3.02 and 200-day moving average was $3.25 The short ratio stood at 22.52 indicating a short percent outstanding of 0%.

Around 1835.8% of the company’s stock are held by insiders while 857.3% are held by institutions.